HeartCycle Project Sets Out to Create Innovative Telemonitoring Solutions

Clothes, bed sheets and home appliances could soon help heart patients to better deal with their condition. The new EU-funded HeartCycle project sets out to create innovative telemonitoring solutions. Launched on 1 March, it is one of the largest biomedical and healthcare research projects in the EU.

The system that the industry-led research consortium is planning to develop will improve the quality of care for coronary heart disease and heart failure patients by monitoring their condition at home, using unobtrusive sensors built into everyday objects. At the same time, the system is intended to report automatically to clinicians, so that they can adapt therapies and make lifestyle recommendations, as well as involve the patients themselves in the management of their disease. The latter is a great challenge as well as a great opportunity, according to Professor John Cleland, head of the Department of Cardiology at the University of Hull, UK. "Investing directly in people who need help, and not just in services that do things to or for them, makes sense in terms of improved care, greater affordability and the effective deployment of scarce nursing and medical resources," he says.

"By developing systems that remotely monitor heart patients and motivate them to adhere to treatment regimes and adopt beneficial lifestyles, we hope to improve the survival of people with heart disease as well as contain the overall cost of care," explains Henk van Houten, senior vice president of Phillips Research and head of the Healthcare Research programme.

"The development of such systems can only be achieved efficiently via multi-disciplinary partnerships between hardware engineers, software engineers, textile manufacturers, industrial designers, clinical experts and healthcare providers, as is the case in the HeartCycle project," Mr van Houten adds.

The public and private 18 project partners from Germany, Greece, Finland, Spain, Portugal, the Netherlands, the UK, Italy, Switzerland and China come from numerous different backgrounds in research, academia, medicine and industry. Over a period of four years, the EU will invest more than €14 million in the HeartCycle research under its Seventh Framework Programme (FP7). The total project cost amounts to nearly €22 million.

HeartCycle builds on the progress made by the MyHeart project, which will end in December 2008 and received funding under the Information Society Technologies (IST) programme of the Sixth Framework Programme (FP6). MyHeart, bringing together some of the same actors, developed advanced telemonitoring technologies and service concepts to enable people to play an active role in maintaining their health. It was during this research that the project partners identified home-based disease management as a potential field for improving medical standards of care, an objective that HeartCycle is trying to achieve with a focus on coronary heart disease.

A total of 1.9 million deaths in the EU every year are the result of cardiovascular diseases, causing annual health costs of €105 billion. Half of those deaths occur in people who have previously had a heart attack, which is why the project partners consider "finding better ways to manage and treat coronary heart disease and chronic heart failure as one of the most effective ways of reducing the human cost and financial burden of these debilitating conditions."

For further information, please visit:
http://www.research.philips.com/

Related news articles:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...